Interferon-Gamma Inducible Protein-10(IP10) as a Predictor of Early Virologic Response in Chronic Hepatitis C Infected Egyptian Patients Stratified for the Interleukin-28B rs12979

Interleukin 28 B genotype as a predictor of response to therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients

The clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin

Changes in chemokines levels in relation to combined interferon and ribavirin therapy in Egyptian patients with chronic hepatitis C

Viral kinetic changes after 4 weeks and its relation to response to Peg. INF therapy in chronic HCV genotype 4 patients

Serum levels of AFP after interferon-based therapy with ribavirin for genotype 4 chronic HCV patients

Prevalence of thyroid dysfunction in Egyptianchronic hepatitis C patients treated with pegylated interferon and ribavirin

Effect of vitamin D supplementation on end treatment response to peginterferon alfa-2b/ribavirin combination in chronic hepatitis c genotype 4

Study of prediction of response to pegylated interferon plus ribavirin in hepatitis C patients by IL28B gene variation and its relation to other different predictors

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin